
1. cytotechnology. 1990 jul;4(1):59-68.

a human hybrid hybridoma producing bispecific monoclonal antibody can
target tumor cells attack pseudomonas aeruginosa exotoxin a.

honda s(1), ichimori y, iwasa s.

author information: 
(1)research development division, takeda chemical industries, ltd., osaka,
japan.

by fusing human hybridoma producing igg2 kappa antibody human a431
epidermoid carcinoma cells epstein-barr virus-transformed human b
lymphocyte producing igg2 kappa antibody pseudomonas aeruginosa
exotoxin a, established hybrid hybridoma producing bispecific monoclonal
antibody reacting a431 cells exotoxin. human igg purified
from culture supernatant hybrid hybridoma, bispecific
monoclonal antibody igg preparation separated two
parental antibodies hydroxyapatite high-performance liquid chromatography. the
human bispecific monoclonal antibody thus obtained efficiently targeted the
antibody-reactive cells, a431, attack exotoxin vitro.

doi: 10.1007/bf00148811 
pmid: 1369279  [indexed medline]

